Filing Details
- Accession Number:
- 0001144204-19-026681
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-05-15 17:59:51
- Reporting Period:
- 2019-05-13
- Accepted Time:
- 2019-05-15 17:59:51
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1661059 | Nextcure Inc. | NXTC | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1202793 | Michael Powell | C/O Sofinnova Investments, Inc. 3000 Sand Hill Road, Bldg. 4, Suite 250 Menlo Park CA 94025 | No | No | Yes | No | |
| 1245624 | James Healy | C/O Sofinnova Investments, Inc. 3000 Sand Hill Road, Bldg. 4, Suite 250 Menlo Park CA 94025 | No | No | Yes | No | |
| 1590102 | Anand Mehra | C/O Sofinnova Investments, Inc. 3000 Sand Hill Road, Bldg. 4, Suite 250 Menlo Park CA 94025 | No | No | Yes | No | |
| 1612133 | Sofinnova Venture Partners Ix, L.p. | C/O Sofinnova Investments, Inc. 3000 Sand Hill Road, Bldg. 4, Suite 250 Menlo Park CA 94025 | No | No | Yes | No | |
| 1612134 | Sofinnova Management Ix, L.l.c. | C/O Sofinnova Investments, Inc. 3000 Sand Hill Road, Bldg. 4, Suite 250 Menlo Park CA 94025 | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-05-13 | 278,759 | $0.00 | 278,759 | No | 4 | C | Direct | |
| Common Stock | Acquisiton | 2019-05-13 | 464,599 | $0.00 | 743,358 | No | 4 | C | Direct | |
| Common Stock | Acquisiton | 2019-05-13 | 908,785 | $0.00 | 1,652,143 | No | 4 | C | Direct | |
| Common Stock | Acquisiton | 2019-05-13 | 469,713 | $0.00 | 2,121,856 | No | 4 | C | Direct | |
| Common Stock | Acquisiton | 2019-05-13 | 400,000 | $15.00 | 2,521,856 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | C | Direct | |
| No | 4 | C | Direct | |
| No | 4 | C | Direct | |
| No | 4 | C | Direct | |
| No | 4 | P | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Series A-1 Preferred Stock | Disposition | 2019-05-13 | 2,239,500 | $0.00 | 278,759 | $0.00 |
| Common Stock | Series A-2 Preferred Stock | Disposition | 2019-05-13 | 3,732,500 | $0.00 | 464,599 | $0.00 |
| Common Stock | Series A-3 Preferred Stock | Disposition | 2019-05-13 | 7,301,000 | $0.00 | 908,785 | $0.00 |
| Common Stock | Series B-1 Preferred Stock | Disposition | 2019-05-13 | 3,773,585 | $0.00 | 469,713 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | No | 4 | C | Direct | ||
| 0 | No | 4 | C | Direct | ||
| 0 | No | 4 | C | Direct | ||
| 0 | No | 4 | C | Direct |
Footnotes
- The reported securities automatically converted into shares of Common Stock on a 1-for-8.0338 basis upon the closing of the Issuer's initial public offering and had no expiration date.
- The shares are held directly by Sofinnova Venture Partners IX, L.P. ("SVP IX"). Sofinnova Management IX, L.L.C. ("SM IX") is the general partner of SVP IX and may be deemed to have sole voting, investment and dispositive power with respect to the shares held by SVP IX. Dr. James I. Healy, Michael F. Powell, Ph.D., and Dr. Anand Mehra are the managing members of SM IX and may be deemed to have shared voting, investment and dispositive power with respect to the shares held by SVP IX. Each of the reporting persons disclaims beneficial ownership of such securities, except to the extent of his, her or its proportionate pecuniary interest therein.
Billionaire Hedge Funds
